Researchers at the University of Leicester have developed a new tool that utilizes Artificial Intelligence (AI) to assess the risk of secondary heart attacks in cancer patients who have already experienced a heart attack.
Key Findings:
- Cancer patients who suffer a heart attack are at a higher risk of complications due to their compromised cardiovascular health.
- These patients face increased chances of mortality, bleeding, or further cardiovascular events.
- The tool, named ONCO-ACS, integrates cancer-specific factors with standard clinical data.
- It predicts the likelihood of death, major bleeding, or another cardiac event within a six-month period.
Study Insights:
The study, published in The Lancet, analyzed data from over one million heart attack patients across England, Sweden, and Switzerland, including more than 47,000 cancer patients. Key statistics include:
- Approximately one in three cancer patients died within six months of a heart attack.
- About one in 14 experienced a major bleed.
- One in six suffered another heart attack, stroke, or cardiovascular death.
Expert Opinions:
Dr. Florian A. Wenzl, the first author of the study, emphasized the long-standing neglect of cancer patients in clinical research, highlighting the challenges they present in cardiology.
Professor David Adlam, a senior author, noted that the overlap between cancer and heart disease is becoming increasingly complex, necessitating tools like ONCO-ACS to guide treatment decisions.
Future Implications:
The researchers aim to integrate the ONCO-ACS score into clinical practice to enhance treatment strategies, particularly regarding catheter-based interventions and antiplatelet therapy. This tool is expected to aid in designing future trials aimed at improving outcomes for cancer patients who have suffered heart attacks.
Professor Thomas F. Lüscher from Imperial College London remarked that ONCO-ACS represents a significant step towards personalized medicine by considering both cancer and heart disease in treatment planning.